Back to top

Truist Financial Sticks to Their Buy Rating for Amphenol (APH)

In a report released today, William Stein from Truist Financial maintained a Buy rating on Amphenol (APH – Research Report). The company’s shares c...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Amphenol Corporation (APH)

SPDR S&P Pharmaceuticals ETF (XPH)